
    
      Double-blind, randomized, controlled clinical trial. The purpose of this study is to evaluate
      the stool composition and GI tolerance of 140 healthy, term infants fed with an infant
      formula with a new fat blend plus L. reuteri vs a standard infant formula. All enrolled
      infants will participate in the trial for approximately 71 days.
    
  